This HEAL Initiative grant is for developing an evidence base for co-occurring Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD). The initiative supports studies focusing on safe and effective medication-assisted, psychosocial, and complementary interventions. Currently, alcohol increases lethal opioid overdose risk, leading to reluctance in prescribing opioid agonist therapies (OATs) to OUD-AUD patients. There’s also limited research on non-pharmacological therapies for this population, where reduced opioid intake can increase drinking and heighten relapse risk. This grant specifically aims to support clinical research project development, including piloting study designs, recruiting subjects, and initiating data collection and analysis pertinent to studying treatment practices for people with OUD-AUD.
Opportunity ID: 350181
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AA-23-006 |
| Funding Opportunity Title: | HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R34 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 12, 2023 |
| Last Updated Date: | Sep 12, 2023 |
| Original Closing Date for Applications: | Dec 14, 2023 |
| Current Closing Date for Applications: | Dec 14, 2023 |
| Archive Date: | Jan 19, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $250,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities State governments Special district governments Native American tribal governments (Federally recognized) County governments Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Independent school districts Private institutions of higher education For profit organizations other than small businesses City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This notice of funding opportunity (NOFO) seeks to support studies that will inform safe and effective medication-assisted, psychosocial, and complementary interventions for people with co-occurring Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD). Alcohol increases lethal opioid overdose risk. As a result, treatment providers may under-prescribe or be reluctant to provide opioid agonist therapies (OATs) such as methadone and buprenorphine to people with OUD who also have AUD or misuse alcohol. There is also scant research on non-pharmacological therapies for people with OUD-AUD. Reciprocal relationships between opioid use and alcohol use has been observed for OUD-AUD patients such that reduced opioid intake may result in increased drinking which heightens opioid relapse and overdose risk and suggests an urgent need for targeted therapies in this population. Research projects dedicated to OUD treatment and prevention, while not excluding subjects who drink, seldom explicitly recruit subjects with AUD. The purpose of this NOFO is to support clinical research project development, including piloting study design and research protocols, subject recruitment, and initiating data collection and analysis pertinent to studying treatment practices for people with OUD-AUD. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-23-006.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 350181 Full Announcement-RFA-AA-23-006 -> RFA-AA-23-006-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00283136 | Nov 14, 2023 | Dec 14, 2023 | View |
Package 1
Mandatory forms
350181 RR_SF424_5_0-5.0.pdf
350181 PHS398_CoverPageSupplement_5_0-5.0.pdf
350181 RR_OtherProjectInfo_1_4-1.4.pdf
350181 PerformanceSite_4_0-4.0.pdf
350181 RR_KeyPersonExpanded_4_0-4.0.pdf
350181 PHS398_ResearchPlan_5_0-5.0.pdf
350181 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
350181 RR_Budget_3_0-3.0.pdf
350181 RR_SubawardBudget30_3_0-3.0.pdf
350181 PHS398_ModularBudget_1_2-1.2.pdf
350181 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
